PUBLISHER: IMARC | PRODUCT CODE: 1451250
PUBLISHER: IMARC | PRODUCT CODE: 1451250
The North America hormone replacement therapy market size reached US$ 4.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 6.9 Billion by 2032, exhibiting a growth rate (CAGR) of 4.7% during 2024-2032
Hormone replacement therapy (HRT) is used for replenishing hormones that are present in low levels in the human body. This treatment is particularly favorable for patients who are experiencing growth hormone deficiency, women nearing menopause and older people suffering from hypogonadism. HRT is available in several forms such as gels, injections, implants, and skin and mouth patches (transdermal). However, it may not be suitable for patients that have a record of blood clots, liver disease and untreated high blood pressure.
North America hormone replacement therapy market is currently being driven by several factors. A surge in the incidences of hormone imbalance disorders, especially in the geriatric and neonatal populations, is spurring the demand for HRT in North America. In line with this, the rising need for new treatment options with better safety results is further catalyzing the market growth in the region. Apart from this, increasing R&D activities for hormone replacement products is enhancing their quality and efficiency. Additionally, the increasing consumer awareness, coupled with the rising technological innovations, such as new gel-based formulations, have also spurred the demand for hormone replacement products in the region.
IMARC Group provides an analysis of the key trends in each sub-segment of the North America hormone replacement therapy market report, along with forecasts at the regional and country level from 2024-2032. Our report has categorized the market based on product, route of administration and type of disease.
Key Regions Analysed
United States
Canada
Mexico
Analysis for Each Country
Market by Product
Estrogen Replacement Therapy
Human Growth Hormone Replacement Therapy
Thyroid Replacement Therapy
Testosterone Replacement Therapy
Others
Market by Route of Administration
Oral
Parenteral
Transdermal
Market by Type of Disease
Menopause
Hypothyroidism
Male Hypogonadism
Growth Hormone Deficiency
Others
Value Chain Analysis
Key Drivers and Challenges
Porters Five Forces Analysis
PESTEL Analysis
Government Regulations
Competitive Landscape
Competitive Structure
Key Player Profiles